PUBLISHER: The Business Research Company | PRODUCT CODE: 1942532
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942532
Cardiovascular medical lasers play a crucial role in treating heart-related medical conditions, particularly during transmyocardial laser revascularization procedures.
The market for cardiovascular medical lasers, as detailed in this report, is divided into excimer lasers and carbon dioxide lasers. Carbon dioxide lasers are instrumental in precisely removing thin skin layers with minimal impact on surrounding tissues. These lasers find applications in various procedures, including laser vascular anastomosis, transmyocardial laser revascularization, and laser angioplasty for peripheral arterial diseases. They are employed by end users like hospitals, specialized clinics, and ambulatory surgery centers.
Tariffs are impacting the cardiovascular medical lasers market by increasing the cost of imported laser sources, optical components, control electronics, cooling systems, and precision manufacturing equipment used in excimer and carbon dioxide laser platforms. Hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported high-precision laser components, while Asia-Pacific faces cost pressures on device manufacturing and system assembly. These tariffs are increasing capital expenditure for healthcare providers and slowing equipment replacement cycles. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic medical laser production capabilities.
The cardiovascular medical lasers market research report is one of a series of new reports from The Business Research Company that provides cardiovascular medical lasers market statistics, including cardiovascular medical lasers industry global market size, regional shares, competitors with a cardiovascular medical lasers market share, detailed cardiovascular medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular medical lasers industry. This cardiovascular medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular medical lasers market size has grown exponentially in recent years. It will grow from $0.44 billion in 2025 to $0.62 billion in 2026 at a compound annual growth rate (CAGR) of 40.8%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing adoption of minimally invasive cardiac procedures, expansion of specialized cardiac care centers, availability of advanced laser technologies, growing clinical acceptance of laser therapies.
The cardiovascular medical lasers market size is expected to see exponential growth in the next few years. It will grow to $2.31 billion in 2030 at a compound annual growth rate (CAGR) of 38.7%. The growth in the forecast period can be attributed to increasing demand for advanced cardiovascular treatments, rising investments in precision cardiac care, growing adoption of laser-assisted surgical procedures, expansion of specialty cardiac hospitals, continuous innovation in medical laser systems. Major trends in the forecast period include increasing adoption of laser-based revascularization procedures, rising use of minimally invasive cardiac laser therapies, growing precision in laser vascular applications, expansion of advanced excimer and co2 laser platforms, enhanced focus on procedure safety and accuracy.
The rising incidence of cardiovascular diseases is expected to drive the growth of the cardiovascular medical lasers market in the coming years. Cardiovascular diseases encompass disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, and stroke. This increase is largely linked to unhealthy eating habits, where excessive consumption of processed foods and fats raises cholesterol levels and heart disease risk. Cardiovascular medical lasers support disease management by providing precise, minimally invasive treatment options that improve blood flow and remove blockages with high accuracy. These devices reduce surgical trauma through targeted laser application, enhancing patient recovery and overall cardiovascular care. For example, in October 2024, according to the U.S. Centers for Disease Control, approximately 919,032 people died from cardiovascular disease in 2023, representing 1 in every 3 deaths. Therefore, the rising incidence of cardiovascular diseases is fueling growth in the cardiovascular medical lasers market.
Leading companies in the cardiovascular medical laser market are focusing on developing non-invasive technologies, including specialized lasers designed to improve treatment outcomes and patient safety. These innovations target conditions such as atherosclerosis and varicose veins. Specialized lasers are engineered for precise applications, optimizing features such as wavelength and output power. They are commonly utilized in medicine, manufacturing, and telecommunications. For instance, in May 2024, Aster Medcity, Kerala's first quaternary care hospital in India, employed excimer laser angioplasty-a minimally invasive procedure-to treat complex cardiovascular conditions by modifying and removing arterial plaque. This approach offers higher success rates, reduces tissue damage, and shortens recovery times.
In August 2024, JC Medical Inc., a U.S.-based medical equipment supplier, acquired Edwards Lifesciences for an undisclosed amount. The acquisition strengthens JC Medical's position in the structural-heart market by leveraging Edwards Lifesciences' advanced heart-valve technologies to support the development of its J-Valve system for treating severe symptomatic native aortic regurgitation. It also enhances JC Medical's product-development capabilities and global reach by integrating Edwards' resources, expertise, and innovation ecosystem. Edwards Lifesciences is a U.S.-based medical technology company specializing in innovative heart-valve therapies and cardiovascular technologies.
Major companies operating in the cardiovascular medical lasers market are Boston Scientific Corporation, Cardiovascular Systems Inc., AngioDynamics Inc., RA Medical Systems Inc., DEKA Research & Development Corporation, EUFOTON S.P.A., Fotona d.d., Gigaa Laser Group, IRIDEX Corporation, Lumenis Ltd., PhotoMedex Inc., Quanta System S.p.A., Vascular Solutions Inc., Spectranetics Corporation, CardioGenesis Corporation, El.En. Group, Asclepion Laser Technologies GmbH, Dornier MedTech GmbH, Laser Engineering Applications (LEA), Biolitec AG
North America was the largest region in the cardiovascular medical lasers market in 2025. Asia-Pacific was the second-largest region in the global cardiovascular medical lasers market report. The regions covered in the cardiovascular medical lasers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiovascular medical lasers market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cardiovascular medical lasers market consists of sales of instruments such as excimer lasers and carbon dioxide lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Medical Lasers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiovascular medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular medical lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular medical lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.